Skip to main content
Department of Health Department of Health An Roinn Sláinte Männystrie O Pouste

Main navigation

  • Home
  • Topics
  • Publications
  • Consultations
  • Contact

Translation help

Translate this page

Select a language

  • Arabic — عربي
  • Chinese (Simplified) — 中文简体
  • Chinese (Traditional) — 中文繁體
  • Dutch — Nederlands
  • Filipino — Filipino
  • French — Français
  • German — Deutsch
  • Hungarian — Magyar
  • Irish — Gaeilge
  • Italian — Italiano
  • Latvian — Latviešu
  • Lithuanian — Lietuvių kalba
  • Polish — Polski
  • Portuguese — Português
  • Romanian — Română
  • Russian — Русский
  • Slovak — Slovenčina
  • Spanish — Español
  • Ukrainian — Українська
  • Drug Alerts - 2021

    Topics:
    • Pharmacy, 
    • Regulation of medicines

    Date published: 3 February 2021

    Last updated: 21 December 2021

    Drug alerts issued by DoH during 2021

    Documents

    • PHC-41-2021 - Class 4 Medicines Defect -McNeil Products Limited - Benylin Chesty Coughs Original (P) - PL 15513 0048Adobe PDF (150.94 KB)
    • PHC-40-2021 - Class 2 Medicines Recall - Wockhardt UK Ltd - Heparin sodium 1,000Adobe PDF (164.67 KB)
    • PHC-39-2021 - Class 4 Medicines Defect - Fresenius Kabi Limited - SmofKabiven Central emulsion for InfusionAdobe PDF (160.27 KB)
    • PHC-38-2021 - Class 2 Medicines Recall - Novartis Pharmaceuticals UK - Lucentis 10 mg ml solution for injection in pre-filled syringeAdobe PDF (137.08 KB)
    • PHC-37-2021 - Class 2 Medicines Recall - Intrapharm Laboratories Ltd - Mydrilate 0.5% Eye Drops, 5ml Adobe PDF (136.69 KB)
    • PHC-36-2021 - Class 2 Medicines Recall - Aventis Pharma Limited T A Sanofi - Co-Aprovel 150mg 12.5mg Film-Coated TabletsAdobe PDF (313.82 KB)
    • PHC-35-2021 - Class 4 Medicines Defect - PilsCo Ltd - Mometasone Furoate 50 Microgram Dose Nasal Spray Suspension - PL 39467 0512 (002)Adobe PDF (142.81 KB)
    • PHC-34-2021 - Class 4 Medicines Defect - Mawdsley-Brooks Company Limited - Diuril Oral Solution (unlicensed medicine)Adobe PDF (125.66 KB)
    • PHC-33-2021- Class 3 Medicines Recall - Methadone 5mg Tablets Physeptone 5mg Tablets - PL 01883 0062 (002)Adobe PDF (135.84 KB)
    • PHC-32-2021- Class 2 Medicines Recall - IKERVIS 1 mg mL eye drops emulsionAdobe PDF (236 KB)
    • PHC-31-2021 - Class 4 Medicines Defect Information - Slenyto 1 mg prolonged-release tablets and Slenyto 5 mg prolonged-release tabletsAdobe PDF (147.8 KB)
    • PHC-30-2021 - Class 2 Medicines Recall - Wrafton Laboratories Limited (trading as Perrigo) - Cold & Flu ReliefAdobe PDF (319.24 KB)
    • PHC 29-2021 - Class 4 Medicines Defect - Vygoris Limited - Mitocin (mitomycin) 20mg powderAdobe PDF (159.33 KB)
    • PHC-28-2021 - Class 3 Medicines Recall - Aspire Pharma Limited - Brimatoprost Aspire Eye DropsAdobe PDF (140.73 KB)
    • PHC-27-2021 - Class 2 Medicines Recall -Pfizer Limited - Champix film-coated tabletsAdobe PDF (183.48 KB)
    • PHC-26-2021 - Class 2 Medicines Recall - Wrafton Laboratoires Limited (trading as Perrigo) - Tesco Flu-Max All In One Chesty Cough ~ PL 12063 0104Adobe PDF (158 KB)
    • PHC-25-2021 - Class 2 Medicines Recall - Accord-UK Ltd (Trading style NorthStar) - LEVOTHYROXINE TABLETS BP 50 - PL 0142 0104Adobe PDF (135.93 KB)
    • PHC-24-2021 - Class 2 Medicines Recall - SANTEN Oy (trading as Santen UK Limited) - IKERVIS 1 mg mL eye drops, - EU 1 15 990 001Adobe PDF (139.27 KB)
    • PHC-23-2021 - Class 4 Medicines Defect - Accord Healthcare Limited - Rosuvastatin film-coated tabletsAdobe PDF (160.72 KB)
    • PHC-22-2021 - Urgent safety communication - Gentamicin Intrathecal 5mg ml Solution - PL17780 0506(2)Adobe PDF (50.71 KB)
    • PHC-21-2021 - Class 2 Medicines Recall - Rosemont Pharmaceuticals Limited - Metformin Hydrochloride 500mg 5mlAdobe PDF (136.66 KB)
    • PHC-20-2021 - Class 2 Medicines Recall -Aventis Pharma Limited T A Sanofi - Aprovel 75mg Film-Coated TabletsAdobe PDF (285.28 KB)
    • PHC-19-2021 - Class 4 Drug Alert - Brown & Burk UK Limited -Amoxicillin 500 mg 5 ml Powder for oral suspension - PL 25298 0248Adobe PDF (39.16 KB)
    • PHC-18-2021 - Class 4 Drug Alert - Napp Pharmaceuticals Limited - Sevredol 10 mg tablets - PL 16950 0063Adobe PDF (173.73 KB)
    • PHC-17-2021 - Class 4 Drug Alert - Galderma UK - Tetralysal 300mg Hard Capsules - PL 10590 0019Adobe PDF (62.1 KB)
    • PHC-16-2021 Class 2 Medicines Recall - Kyowa Kirin Limited - Xomolix 2.5 mg ml solution for injection - PL 16508 0036Adobe PDF (224.83 KB)
    • PHC-15-2021 Class 2 Medicines Recall - Irbesartan Hydrochlorothiazide Losartan - Bristol Laboratories ~ containing and Losartan(3)Adobe PDF (174.51 KB)
    • PHC-14-2021 Class-1 Recall - Co-codamol 30 500 Effervescent Tablets -NatPSA-2021-004-MHRA-PL 17780-0046Adobe PDF (408.44 KB)
    • PHC-13-2021 Class 3 Recall - Advanz Pharma - Carbimazole 10mg Tablets - PL 20072 0244 PL 20072 0245Adobe PDF (142.63 KB)
    • PHC-12-2021 Class 2 Medicines Recall - AstraZeneca UK Limited - Bricanyl Injection, 0.5 mg ml solution for ~ PL 17901 0112Adobe PDF (138.7 KB)
    • PHC-11-2021 Class 4 Defect - Lupin Healthcare (UK) Limited - Syonell 250mg Gastro-Resistant Tablets - PL 35507 0191Adobe PDF (60.24 KB)
    • PHC-10-2021 - Class 2 Recall - Ennogen Pharma Limited - Trimethoprim 200mg Tablets - PL 40147/0083Adobe PDF (151.73 KB)
    • PHC-09-2021 - Class 4 Defect - Macarthys Labratories T A Martindale Pharma - Caffeine ~ PL 01883 0344Adobe PDF (139.96 KB)
    • PHC-08-2021 - Class 3 Recall - Thame Laboratories - Itraconazole 10mg ml Oral Solution - PL 39307 0069Adobe PDF (139.05 KB)
    • PHC/7/2021 - Class 4 Defect - Accord-UK Ltd - Diazepam 2mg 5ml Oral Solution Sugar Free - PL 0142 0103Adobe PDF (213.46 KB)
    • PHC/6/2021 - Class 3 Recall - Orion ~ Easyhaler Salbutamol Sulfate 100 micrograms per actuation inhalation powder PL 27925 0002Adobe PDF (138.93 KB)
    • PHC/5/2021 - Class 3 Recall - SyriMed - Clonidine hydrochloride 50micrograms 5ml Oral ~ PL 39307 0082Adobe PDF (136.12 KB)
    • PHC/4/2021 - Class 2 Recall - Eaststone Limited -MidaBuc - Midazolam (as HCL) 10mgmL Oromucosal Solution -Unlicensed Medicine - MS 32967 (1)Adobe PDF (138.07 KB)
    • PHC/3/2021 - Class 4 Notification Gilead Sciences Ltd AmBisome Liposomal 50 mg Powder for dispersion for infusion - PL 16807 0001Adobe PDF (165.49 KB)
    • PHC/2/2021 - Class 3 Drug Alert Intrapharm Laboratories Ltd - KolanticonClass 2 Recall - Grünenthal Ltd Palexia 20 mg ml Oral Solution - PL 21727 0054Adobe PDF (215.4 KB)
    • PHC/1/2021 - Class 3 Drug Alert Intrapharm Laboratories Ltd - KolanticonAdobe PDF (317.2 KB)
    Share this page Share on Facebook (external link opens in a new window / tab) Share on X (external link opens in a new window / tab) Share by email (external link opens in a new window / tab)

    Department footer links

    • Crown copyright
    • Terms and Conditions
    • Privacy
    • Cookies
    • Accessibility
    • The Northern Ireland Executive
    • The Executive Office
    • Department of Agriculture, Environment and Rural Affairs
    • Department for Communities
    • Department for Education
    • Department for the Economy
    • Department of Finance
    • Department for Infrastructure
    • Department for Health
    • Department of Justice
    • nidirect.gov.uk — the official government website for Northern Ireland citizens